Skip to content

Clinical trials

Phase 2 Respiratory Tract Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Diseases Phase: Phase 2 Country / region: United States Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20031
20071
20082
20091
20101
20131
20141
20164
20172
20181
20192
20201
20212
20222
20233
20243
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Terminated6
Active, not recruiting3
Recruiting3
Withdrawn2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Medicago3
Upstream Bio Inc.3
AstraZeneca2
National Center for Research Resources (NCRR)2
Pfizer2
Vertex Pharmaceuticals Incorporated2
Biomedical Advanced Research and Development Authority1
Cardeas Pharma1
Celgene1
Columbia University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Diseases38
Lung Diseases19
Respiratory Tract Infections13
Asthma8
Infections8
Virus Diseases8
Bronchial Diseases6
RNA Virus Infections6
Fibrosis5
Influenza, Human5

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.